Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies. Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series
创建时间：
2016-03-07
